{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:42:01Z","timestamp":1793814121554,"version":"4.6.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"DOI":"10.1186\/s12906-025-04918-7","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:41:41Z","timestamp":1748004101000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse model"],"prefix":"10.1186","volume":"25","author":[{"given":"Anuththara Upamali","family":"Abeykoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhavi Priyanka","family":"Paranagama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavindra Kumara","family":"Wijesundera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onela Canith","family":"Pathirana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thilini Anupama","family":"Mahakapuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayantha","family":"Rajapakse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"4918_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, et al. The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328\u201357. https:\/\/doi.org\/10.1002\/hep.29367.","journal-title":"Hepatology"},{"key":"4918_CR2","doi-asserted-by":"publisher","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","volume":"9","author":"M Benedict","year":"2017","unstructured":"Benedict M, Zhang X. Non-alcoholic fatty liver disease: an expanded review. World J Hepatol. 2017;9:715\u201332. https:\/\/doi.org\/10.4254\/wjh.v9.i16.715.","journal-title":"World J Hepatol"},{"key":"4918_CR3","doi-asserted-by":"publisher","first-page":"S32","DOI":"10.3350\/cmh.2022.0365","volume":"29","author":"ML Teng","year":"2023","unstructured":"Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, et al. Global incidence and prevalence of nonalcoholic fatty liver disease. Clin Mol Hepatol. 2023;29:S32\u201342. https:\/\/doi.org\/10.3350\/cmh.2022.0365.","journal-title":"Clin Mol Hepatol"},{"key":"4918_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3350\/cmh.2022.0239","volume":"28","author":"MH Le","year":"2022","unstructured":"Le MH, Yeo YH, Zou B, Barnet S, Henry L, Cheung R, et al. Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach. Clin Mol Hepatol. 2022;28:841\u201350. https:\/\/doi.org\/10.3350\/cmh.2022.0239.","journal-title":"Clin Mol Hepatol"},{"key":"4918_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41575-020-0315-7","volume":"17","author":"JV Lazarus","year":"2020","unstructured":"Lazarus JV, Colombo M, Cortez-Pinto H, Huang TT-K, Miller V, Ninburg M, et al. NAFLD \u2014 sounding the alarm on a silent epidemic. Nat Rev Gastroenterol Hepatol. 2020;17:377\u20139. https:\/\/doi.org\/10.1038\/s41575-020-0315-7.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4918_CR6","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.3748\/wjg.v30.i22.2829","volume":"30","author":"H Lv","year":"2024","unstructured":"Lv H, Liu Y. Management of non-alcoholic fatty liver disease: lifestyle changes. World J Gastroenterol. 2024;30:2829\u201333. https:\/\/doi.org\/10.3748\/wjg.v30.i22.2829.","journal-title":"World J Gastroenterol"},{"key":"4918_CR7","doi-asserted-by":"crossref","unstructured":"The Role of Antioxidants in the Treatment of Metabolic Dysfunction-Associated Fatty Liver Disease: A Systematic Review n.d. https:\/\/www.mdpi.com\/2076-3921\/13\/7\/797. Accessed September 26, 2024.","DOI":"10.3390\/antiox13070797"},{"key":"4918_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.4254\/wjh.v16.i2.152","volume":"16","author":"A Viswanath","year":"2024","unstructured":"Viswanath A, Fouda S, Fernandez CJ, Pappachan JM. Metabolic-associated fatty liver disease and sarcopenia: A double whammy. World J Hepatol. 2024;16:152\u201363. https:\/\/doi.org\/10.4254\/wjh.v16.i2.152.","journal-title":"World J Hepatol"},{"key":"4918_CR9","unstructured":"Diabetes. accessed September 26, n.d. 2024. https:\/\/www.who.int\/health-topics\/diabetes."},{"key":"4918_CR10","unstructured":"Commissioner O of the. FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease. FDA 2024. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease (accessed September 26, 2024)."},{"key":"4918_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa2309000","volume":"390","author":"SA Harrison","year":"2024","unstructured":"Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, et al. A phase 3, randomized, controlled trial of Resmetirom in NASH with liver fibrosis. N Engl J Med. 2024;390:497\u2013509. https:\/\/doi.org\/10.1056\/NEJMoa2309000.","journal-title":"N Engl J Med"},{"key":"4918_CR12","doi-asserted-by":"publisher","first-page":"6890","DOI":"10.3748\/wjg.v22.i30.6890","volume":"22","author":"H Yao","year":"2016","unstructured":"Yao H, Qiao Y-J, Zhao Y-L, Tao X-F, Xu L-N, Yin L-H, et al. Herbal medicines and nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22:6890\u2013905. https:\/\/doi.org\/10.3748\/wjg.v22.i30.6890.","journal-title":"World J Gastroenterol"},{"key":"4918_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.3389\/fphar.2020.00601","volume":"11","author":"Y Xu","year":"2020","unstructured":"Xu Y, Guo W, Zhang C, Chen F, Tan HY, Li S, et al. Herbal medicine in the treatment of Non-Alcoholic fatty liver Diseases-Efficacy, action mechanism, and clinical application. Front Pharmacol. 2020;11:601. https:\/\/doi.org\/10.3389\/fphar.2020.00601.","journal-title":"Front Pharmacol"},{"key":"4918_CR14","doi-asserted-by":"publisher","first-page":"1362391","DOI":"10.3389\/fphar.2024.1362391","volume":"15","author":"M-H Kim","year":"2024","unstructured":"Kim M-H, Ahn S, Hur N, Oh S-Y, Son C-G. The additive effect of herbal medicines on lifestyle modification in the treatment of non-alcoholic fatty liver disease: a systematic review and meta-analysis. Front Pharmacol. 2024;15:1362391. https:\/\/doi.org\/10.3389\/fphar.2024.1362391.","journal-title":"Front Pharmacol"},{"key":"4918_CR15","volume-title":"Sinhalese materia medica","author":"J Attygalle","year":"1952","unstructured":"Attygalle J. Sinhalese materia medica. Colombo [Ceylon]: Gunasena; 1952."},{"key":"4918_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1055\/s-2006-962691","volume":"53","author":"MI Thabrew","year":"1987","unstructured":"Thabrew MI, Joice PD, Rajatissa W. A comparative study of the efficacy of Pavetta indica and Osbeckia Octandra in the treatment of liver dysfunction. Planta Med. 1987;53:239\u201341. https:\/\/doi.org\/10.1055\/s-2006-962691.","journal-title":"Planta Med"},{"key":"4918_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0378-8741(95)90033-0","volume":"49","author":"MI Thabrew","year":"1995","unstructured":"Thabrew MI, Gove CD, Hughes RD, McFarlane IG, Williams R. Protective effects of Osbeckia Octandra against galactosamine and tert-butyl hydroperoxide induced hepatocyte damage. J Ethnopharmacol. 1995;49:69\u201376. https:\/\/doi.org\/10.1016\/0378-8741(95)90033-0.","journal-title":"J Ethnopharmacol"},{"key":"4918_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1055\/s-2006-961906","volume":"55","author":"KA Jayathilaka","year":"1989","unstructured":"Jayathilaka KA, Thabrew MI, Pathirana C, de Silva DG, Perera DJ. An evaluation of the potency of Osbeckia Octandra and Melothria Maderaspantana as antihepatotoxic agents. Planta Med. 1989;55:137\u20139. https:\/\/doi.org\/10.1055\/s-2006-961906.","journal-title":"Planta Med"},{"key":"4918_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3109\/00498259509046671","volume":"25","author":"MI Thabrew","year":"1995","unstructured":"Thabrew MI, Hughes RD, Gove CD, Portmann B, Williams R, McFarlane IG. Protective effects of Osbeckia Octandra against paracetamol-induced liver injury. Xenobiotica. 1995;25:1009\u201317. https:\/\/doi.org\/10.3109\/00498259509046671.","journal-title":"Xenobiotica"},{"key":"4918_CR20","doi-asserted-by":"publisher","first-page":"4836","DOI":"10.3390\/molecules26164836","volume":"26","author":"S Bogahawaththa","year":"2021","unstructured":"Bogahawaththa S, Kodithuwakku SP, Wijesundera KK, Siriweera EH, Jayasinghe L, Dissanayaka WL, et al. Anti-Fibrotic and Anti-Angiogenic activities of Osbeckia Octandra leaf extracts in Thioacetamide-Induced experimental liver cirrhosis. Molecules. 2021;26:4836. https:\/\/doi.org\/10.3390\/molecules26164836.","journal-title":"Molecules"},{"key":"4918_CR21","unstructured":"Leelaprakash G, Dass SM. V.Sivajothi. Antioxidant and hepatoprotective activities of vernonia cinerea extract against CCL4 induced hepatotoxicity in albino rats. Int J Pharm Sci Rev Res. 2011;10."},{"key":"4918_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1093\/bbb\/zbad114","volume":"87","author":"S Bogahawaththa","year":"2023","unstructured":"Bogahawaththa S, Kawamura T, Bandaranayake U, Hirakawa T, Yamada G, Ishino H, et al. Identification and mechanistic investigation of ellagitannins from Osbeckia Octandra that attenuate liver fibrosis via the TGF-\u03b2\/SMAD signaling pathway. Biosci Biotechnol Biochem. 2023;87:1295\u2013309. https:\/\/doi.org\/10.1093\/bbb\/zbad114.","journal-title":"Biosci Biotechnol Biochem"},{"key":"4918_CR23","unstructured":"Hettihewa SK, Sanketha PD, Silva A. Phytochemical evaluation, in-vitro radical scavenging and antioxidant activities of aqueous leaf extract of Heen bovitiya (Osbeckia Octandra L. (DC.) grown in Sri Lanka. 2021."},{"key":"4918_CR24","unstructured":"Perera PRD, Ekanayake S. In vitro study on antiglycation activity, antioxidant activity and phenolic content of Osbeckia Octandra L. leaf decoction. J Pharmacogn Phytochem. 2013;4:198\u2013201."},{"key":"4918_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1248\/cpb.51.425","volume":"51","author":"Y-H Kuo","year":"2003","unstructured":"Kuo Y-H, Kuo Y-J, Yu A-S, Wu M-D, Ong C-W, Yang Kuo L-M, et al. Two novel sesquiterpene lactones, cytotoxic Vernolide-A and -B, from Vernonia cinerea. Chem Pharm Bull. 2003;51:425\u20136. https:\/\/doi.org\/10.1248\/cpb.51.425.","journal-title":"Chem Pharm Bull"},{"key":"4918_CR26","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.cbi.2015.12.002","volume":"245","author":"R Asha","year":"2016","unstructured":"Asha R, Gayathri Devi V, Abraham A. Lupeol, a pentacyclic triterpenoid isolated from Vernonia cinerea attenuate selenite induced cataract formation in Sprague Dawley rat pups. Chemico-Biol Interact. 2016;245:20\u20139. https:\/\/doi.org\/10.1016\/j.cbi.2015.12.002.","journal-title":"Chemico-Biol Interact"},{"key":"4918_CR27","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1021\/np50035a020","volume":"47","author":"TN Misra","year":"1984","unstructured":"Misra TN, Singh RS, Upadhyay J, Srivastava R. Chemical constituents of Vernonia cinerea. Isolation and structure Elucidation of a new pentacyclic triterpenoid. J Nat Prod. 1984;47:865\u20137. https:\/\/doi.org\/10.1021\/np50035a020.","journal-title":"J Nat Prod"},{"key":"4918_CR28","doi-asserted-by":"publisher","unstructured":"Haque. Phytochemical investigation of Vernonia cinerea(Family: Asteraceae). J App Pharm Sci. 2012. https:\/\/doi.org\/10.7324\/JAPS.2012.2617.","DOI":"10.7324\/JAPS.2012.2617"},{"key":"4918_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/DDDT.S126882","volume":"11","author":"N Ketsuwan","year":"2017","unstructured":"Ketsuwan N, Leelarungrayub J, Kothan S, Singhatong S. Antioxidant compounds and activities of the stem, flower, and leaf extracts of the anti-smoking Thai medicinal plant: Vernonia cinerea less. Drug Des Devel Ther. 2017;11:383\u201391. https:\/\/doi.org\/10.2147\/DDDT.S126882.","journal-title":"Drug Des Devel Ther"},{"key":"4918_CR30","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3109\/13880209.2011.604334","volume":"49","author":"R Rajamurugan","year":"2011","unstructured":"Rajamurugan R, Selvaganabathy N, Kumaravel S, Ramamurthy C, Sujatha V, Suresh Kumar M, et al. Identification, quantification of bioactive constituents, evaluation of antioxidant and in vivo acute toxicity property from the methanol extract of Vernonia cinerea leaf extract. Pharm Biol. 2011;49:1311\u201320. https:\/\/doi.org\/10.3109\/13880209.2011.604334.","journal-title":"Pharm Biol"},{"key":"4918_CR31","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3109\/01480545.2010.520017","volume":"34","author":"P Pratheeshkumar","year":"2011","unstructured":"Pratheeshkumar P, Kuttan G. Vernolide-A, a sesquiterpene lactone from Vernonia cinerea, induces apoptosis in B16F-10 melanoma cells by modulating p53 and caspase-3 gene expressions and regulating NF-\u03baB-mediated bcl-2 activation. Drug Chem Toxicol. 2011;34:261\u201370. https:\/\/doi.org\/10.3109\/01480545.2010.520017.","journal-title":"Drug Chem Toxicol"},{"key":"4918_CR32","first-page":"1","volume":"25","author":"C Gokilaveni","year":"2006","unstructured":"Gokilaveni C, Nishadh A, Selvi V. Ameliorative role of Vernonia cinerea in carbon tetrachloride induced hepatic dysfunction in rats. Anc Sci Life. 2006;25:1\u20135.","journal-title":"Anc Sci Life"},{"key":"4918_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.nutres.2018.04.020","volume":"56","author":"J Naowaboot","year":"2018","unstructured":"Naowaboot J, Wannasiri S, Pannangpetch P. Vernonia cinerea water extract improves insulin resistance in high-fat diet\u2013induced obese mice. Nutr Res. 2018;56:51\u201360. https:\/\/doi.org\/10.1016\/j.nutres.2018.04.020.","journal-title":"Nutr Res"},{"key":"4918_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.12691\/wjar-8-3-3","volume":"8","author":"Rm D","year":"2020","unstructured":"D Rm. J.a.t.u J, L.d.a.m A, D.l.c.k F. Compositional analysis of volatile compounds of Paspangiri - A mixture of leaves of five Rutaceae plants used as an effective remedy for respiratory system microbial infections in traditional systems of medicine. World J Agricultural Res. 2020;8:84\u20138. https:\/\/doi.org\/10.12691\/wjar-8-3-3.","journal-title":"World J Agricultural Res"},{"key":"4918_CR35","doi-asserted-by":"publisher","unstructured":"Fraser AW, Lewis JR. Rutaceous constitutents. Part II. Two acridone alkaloids from Atalantia ceylanica(Rutaceae). J Chem Soc Perkin Trans 1 1973:1173\u20135. https:\/\/doi.org\/10.1039\/P19730001173","DOI":"10.1039\/P19730001173"},{"key":"4918_CR36","doi-asserted-by":"crossref","unstructured":"Bowen IH, Patel YN. Acridone alkaloids and other constituents of the leaves of Atalantia ceylanica. Planta Med. 1987.","DOI":"10.1055\/s-2006-962624"},{"key":"4918_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1472-6882-14-395","volume":"14","author":"CD Fernando","year":"2014","unstructured":"Fernando CD, Soysa P. Total phenolic, flavonoid contents, in-vitro antioxidant activities and hepatoprotective effect of aqueous leaf extract of Atalantia ceylanica. BMC Complement Altern Med. 2014;14:395. https:\/\/doi.org\/10.1186\/1472-6882-14-395.","journal-title":"BMC Complement Altern Med"},{"key":"4918_CR38","unstructured":"Phytochemicals. Antioxidant capacity of selected Rutaceae species used in Sri Lanka. Res J Chem Sci. 2020;10:48\u201352."},{"key":"4918_CR39","doi-asserted-by":"publisher","first-page":"100208","DOI":"10.1016\/j.focha.2023.100208","volume":"2","author":"S Ulpathakumbura","year":"2023","unstructured":"Ulpathakumbura S, Marikkar N, Jayasinghe L. Anti-oxidative, anti-hyperglycemic and anti-obesity properties of selected edible leafy plants of Sri Lanka. Food Chem Adv. 2023;2:100208. https:\/\/doi.org\/10.1016\/j.focha.2023.100208.","journal-title":"Food Chem Adv"},{"key":"4918_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4038\/cmj.v59i1.6731","volume":"59","author":"S Senadheera","year":"2014","unstructured":"Senadheera S, Ekanayake S, Wanigatunge C. Antioxidant potential of green leafy porridges. Ceylon Med J. 2014;59:4\u20138. https:\/\/doi.org\/10.4038\/cmj.v59i1.6731.","journal-title":"Ceylon Med J"},{"key":"4918_CR41","doi-asserted-by":"publisher","first-page":"443","DOI":"10.9734\/sarjnp\/2024\/v7i3175","volume":"7","author":"SP Wijekoon","year":"2024","unstructured":"Wijekoon SP, Herath AT. Biological activities, therapeutic potential and phytochemical screening of Atalantia Ceylanica: A Mini review. South Asian Res J Nat Prod. 2024;7:443\u201350. https:\/\/doi.org\/10.9734\/sarjnp\/2024\/v7i3175.","journal-title":"South Asian Res J Nat Prod"},{"key":"4918_CR42","doi-asserted-by":"publisher","unstructured":"Upadhyay DRK. Antihyperlipidemic and cardioprotective effects of plant natural products: A review. Int J Green Pharm (IJGP). 2021;15. https:\/\/doi.org\/10.22377\/ijgp.v15i1.3011.","DOI":"10.22377\/ijgp.v15i1.3011"},{"key":"4918_CR43","unstructured":"GPS coordinate converter n.d. https:\/\/www.gps-coordinates.net\/gps-coordinates-converter (accessed November 30, 2024)."},{"key":"4918_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s12906-020-03048-6","volume":"20","author":"MP Paranagama","year":"2020","unstructured":"Paranagama MP, Piyarathne NS, Nandasena TL, Jayatilake S, Navaratne A, Galhena BP, et al. The Porphyromonas gingivalis inhibitory effects, antioxidant effects and the safety of a Sri Lankan traditional betel quid - an in vitro study. BMC Complement Med Ther. 2020;20:259. https:\/\/doi.org\/10.1186\/s12906-020-03048-6.","journal-title":"BMC Complement Med Ther"},{"key":"4918_CR45","doi-asserted-by":"publisher","first-page":"e121522","DOI":"10.1590\/fst.121522","volume":"43","author":"S-J Hwang","year":"2023","unstructured":"Hwang S-J, Lee J-H. Comparison of antioxidant activities expressed as equivalents of standard antioxidant. Food Sci Technol. 2023;43:e121522. https:\/\/doi.org\/10.1590\/fst.121522.","journal-title":"Food Sci Technol"},{"key":"4918_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0891-5849(98)00315-3","volume":"26","author":"R Re","year":"1999","unstructured":"Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999;26:1231\u20137. https:\/\/doi.org\/10.1016\/S0891-5849(98)00315-3.","journal-title":"Free Radic Biol Med"},{"key":"4918_CR47","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1385\/1-59259-687-8:25","volume-title":"Cell sensitivity assays: the MTT assay. Cytotoxic drug resistance mechanisms","author":"JA Plumb","year":"1999","unstructured":"Plumb JA. Cell sensitivity assays: the MTT assay. Cytotoxic drug resistance mechanisms. Volume 28. New Jersey: Humana; 1999. pp. 25\u201330. https:\/\/doi.org\/10.1385\/1-59259-687-8:25."},{"key":"4918_CR48","unstructured":"Animals NRC (US) C for the U of the G for the C and U of L., Environment, editors. Housing, and Management. Guide for the Care and Use of Laboratory Animals. 8th edition, National Academies Press (US); 2011."},{"key":"4918_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1139\/apnm-2019-0139","volume":"45","author":"VS Panda","year":"2020","unstructured":"Panda VS, Shah T. A herbal Premix containing Macrotyloma uniflorum, Ginger, and Whey curtails obesity in rats fed a high-fat diet by a novel mechanism. Appl Physiol Nutr Metab. 2020;45:24\u201334. https:\/\/doi.org\/10.1139\/apnm-2019-0139.","journal-title":"Appl Physiol Nutr Metab"},{"key":"4918_CR50","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4068\/cmj.2024.60.1.13","volume":"60","author":"Z Eslami","year":"2024","unstructured":"Eslami Z, Aghili SS, Ghafi AG. Atorvastatin on treatment of nonalcoholic fatty liver disease patients. Chonnam Med J. 2024;60:13\u201320. https:\/\/doi.org\/10.4068\/cmj.2024.60.1.13.","journal-title":"Chonnam Med J"},{"key":"4918_CR51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7:27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703.","journal-title":"J Basic Clin Pharm"},{"key":"4918_CR52","doi-asserted-by":"publisher","unstructured":"Roustan A, Perrin J, Courbiere B, Reply. Mouse euthanasia by isoflurane inhalation: a controversial method for the animal welfare and a negative impact on oocyte quality. Lab Anim. 2012;46:360\u2013360. https:\/\/doi.org\/10.1258\/la.2012.012130.","DOI":"10.1258\/la.2012.012130"},{"key":"4918_CR53","doi-asserted-by":"publisher","first-page":"1700696","DOI":"10.1002\/mnfr.201700696","volume":"62","author":"J Huang","year":"2018","unstructured":"Huang J, Feng S, Liu A, Dai Z, Wang H, Reuhl K, et al. Green tea polyphenol EGCG alleviates metabolic abnormality and fatty liver by decreasing bile acid and lipid absorption in mice. Mol Nutr Food Res. 2018;62:1700696. https:\/\/doi.org\/10.1002\/mnfr.201700696.","journal-title":"Mol Nutr Food Res"},{"key":"4918_CR54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1111\/1751-2980.12610","volume":"19","author":"YY Li","year":"2018","unstructured":"Li YY, Tang D, Du YL, Cao CY, Nie YQ, Cao J, et al. Fatty liver mediated by peroxisome proliferator-activated receptor-\u03b1 DNA methylation can be reversed by a methylation inhibitor and Curcumin. J Dig Dis. 2018;19:421\u201330. https:\/\/doi.org\/10.1111\/1751-2980.12610.","journal-title":"J Dig Dis"},{"key":"4918_CR55","unstructured":"Use of glyceraldehyde. 3-phosphate dehydrogenase (GAPDH) as internal control in Western-blot experiments? - MedCrave online n.d. https:\/\/medcraveonline.com\/JCPCR\/use-of-glyceraldehyde-3-phosphate-dehydrogenase-gapdh-as-internal-control-in-western-blot-experiments.html (accessed October 24, 2024)."},{"key":"4918_CR56","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321. https:\/\/doi.org\/10.1002\/hep.20701.","journal-title":"Hepatology"},{"key":"4918_CR57","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41575-018-0055-0","volume":"16","author":"MCS Wong","year":"2019","unstructured":"Wong MCS, Huang JLW, George J, Huang J, Leung C, Eslam M, et al. The changing epidemiology of liver diseases in the Asia-Pacific region. Nat Rev Gastroenterol Hepatol. 2019;16:57\u201373. https:\/\/doi.org\/10.1038\/s41575-018-0055-0.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4918_CR58","doi-asserted-by":"publisher","unstructured":"Makri E, Goulas A, Polyzos SA, Epidemiology. Pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease. Arch Med Res. 2021;52:25\u201337. https:\/\/doi.org\/10.1016\/j.arcmed.2020.11.010.","DOI":"10.1016\/j.arcmed.2020.11.010"},{"key":"4918_CR59","unstructured":"Weerasinghe P, Abeysinghe T, Paranagama PA. Assessment of in vitro antioxidant activity and flavonoid content Vernonia cinerea 2019."},{"key":"4918_CR60","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.3390\/antiox11071347","volume":"11","author":"R Banc","year":"2022","unstructured":"Banc R, Popa D-S, Cozma-Petru\u021b A, Lorena F, Kiss B, F\u0103rca\u015f A, et al. Protective effects of wine polyphenols on oxidative stress and hepatotoxicity induced by acrylamide in rats. Antioxidants. 2022;11:1347. https:\/\/doi.org\/10.3390\/antiox11071347.","journal-title":"Antioxidants"},{"key":"4918_CR61","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.3390\/antiox12061212","volume":"12","author":"IF Machado","year":"2023","unstructured":"Machado IF, Miranda RG, Dorta DJ, Rolo AP, Palmeira CM. Targeting oxidative stress with polyphenols to fight liver diseases. Antioxidants. 2023;12:1212. https:\/\/doi.org\/10.3390\/antiox12061212.","journal-title":"Antioxidants"},{"key":"4918_CR62","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1002\/hep.23280","volume":"51","author":"E Fabbrini","year":"2010","unstructured":"Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic and clinical implications. Hepatology. 2010;51:679\u201389. https:\/\/doi.org\/10.1002\/hep.23280.","journal-title":"Hepatology"},{"key":"4918_CR63","doi-asserted-by":"publisher","first-page":"100346","DOI":"10.1016\/j.jhepr.2021.100346","volume":"3","author":"L Parlati","year":"2021","unstructured":"Parlati L, R\u00e9gnier M, Guillou H, Postic C. New targets for NAFLD. JHEP Rep. 2021;3:100346. https:\/\/doi.org\/10.1016\/j.jhepr.2021.100346.","journal-title":"JHEP Rep"},{"key":"4918_CR64","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/biology11050792","volume":"11","author":"S Todisco","year":"2022","unstructured":"Todisco S, Santarsiero A, Convertini P, De Stefano G, Gilio M, Iacobazzi V, et al. PPAR alpha as a metabolic modulator of the liver: role in the pathogenesis of nonalcoholic steatohepatitis (NASH). Biology (Basel). 2022;11:792. https:\/\/doi.org\/10.3390\/biology11050792.","journal-title":"Biology (Basel)"},{"key":"4918_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","volume":"15","author":"Y Geng","year":"2021","unstructured":"Geng Y, Faber KN, de Meijer VE, Blokzijl H, Moshage H. How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease? Hepatol Int. 2021;15:21\u201335. https:\/\/doi.org\/10.1007\/s12072-020-10121-2.","journal-title":"Hepatol Int"},{"key":"4918_CR66","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","volume":"28","author":"L Chrysavgis","year":"2022","unstructured":"Chrysavgis L, Giannakodimos I, Diamantopoulou P, Cholongitas E. Non-alcoholic fatty liver disease and hepatocellular carcinoma: clinical challenges of an intriguing link. World J Gastroenterol. 2022;28:310\u201331. https:\/\/doi.org\/10.3748\/wjg.v28.i3.310.","journal-title":"World J Gastroenterol"},{"key":"4918_CR67","doi-asserted-by":"publisher","first-page":"1005312","DOI":"10.3389\/fphar.2022.1005312","volume":"13","author":"P Tan","year":"2022","unstructured":"Tan P, Jin L, Qin X, He B. Natural flavonoids: potential therapeutic strategies for non-alcoholic fatty liver disease. Front Pharmacol. 2022;13:1005312. https:\/\/doi.org\/10.3389\/fphar.2022.1005312.","journal-title":"Front Pharmacol"},{"key":"4918_CR68","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.bbrc.2011.11.102","volume":"417","author":"X-Y Luo","year":"2012","unstructured":"Luo X-Y, Takahara T, Hou J, Kawai K, Sugiyama T, Tsukada K, et al. Theaflavin attenuates ischemia\u2013reperfusion injury in a mouse fatty liver model. Biochem Biophys Res Commun. 2012;417:287\u201393. https:\/\/doi.org\/10.1016\/j.bbrc.2011.11.102.","journal-title":"Biochem Biophys Res Commun"},{"key":"4918_CR69","doi-asserted-by":"publisher","unstructured":"Rodriguez-Ramiro I, Vauzour D, Minihane AM. Polyphenols and non-alcoholic fatty liver disease: impact and mechanisms. Proc Nutr Soc. 2016;75:47\u201360. https:\/\/doi.org\/10.1017\/S0029665115004218","DOI":"10.1017\/S0029665115004218"},{"key":"4918_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/8394818","volume":"2018","author":"S Li","year":"2018","unstructured":"Li S, Tan HY, Wang N, Cheung F, Hong M, Feng Y. The potential and action mechanism of polyphenols in the treatment of liver diseases. Oxidative Med Cell Longev. 2018;2018:1\u201325. https:\/\/doi.org\/10.1155\/2018\/8394818.","journal-title":"Oxidative Med Cell Longev"},{"key":"4918_CR71","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ajoms.2020.09.003","volume":"33","author":"M Prasadani","year":"2021","unstructured":"Prasadani M, Bogahawaththa S, Illeperuma RP, Kodithuwakku SP. Leaf extract of Osbeckia Octandra L. (Heen Bovitiya) suppresses human oral squamous cell carcinoma cells migration and induces cellular DNA damage. J Oral Maxillofacial Surg Med Pathol. 2021;33:215\u201320. https:\/\/doi.org\/10.1016\/j.ajoms.2020.09.003.","journal-title":"J Oral Maxillofacial Surg Med Pathol"},{"key":"4918_CR72","doi-asserted-by":"publisher","unstructured":"Leelarungrayub D, Ketsuwan N, Kothan S, Singhatong S. Antioxidant compounds and activities of the stem, flower, and leaf extracts of the anti-smoking Thai medicinal plant: Vernonia cinerea Less. Drug Des Devel Ther. 2017;11:383\u201391. https:\/\/doi.org\/10.2147\/DDDT.S126882","DOI":"10.2147\/DDDT.S126882"},{"key":"4918_CR73","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s13659-024-00445-z","volume":"14","author":"T Merenda","year":"2024","unstructured":"Merenda T, Juszczak F, Ferier E, Duez P, Patris S, Decl\u00e8ves A-\u00c9, et al. Natural compounds proposed for the management of non-alcoholic fatty liver disease. Nat Prod Bioprospect. 2024;14:24. https:\/\/doi.org\/10.1007\/s13659-024-00445-z.","journal-title":"Nat Prod Bioprospect"},{"key":"4918_CR74","doi-asserted-by":"publisher","unstructured":"Grayer RJ, Thabrew MI, Hughes RD, Bretherton S, Lever A, Veitch NC, et al. Phenolic and terpenoid constituents from the Sri Lankan medicinal plant Osbeckia aspera. Pharm Biol. 2008;46:154\u201361. https:\/\/doi.org\/10.1080\/13880200701538682.","DOI":"10.1080\/13880200701538682"},{"key":"4918_CR75","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/14786419.2021.1881959","volume":"36","author":"RK Sharma","year":"2022","unstructured":"Sharma RK, Sharma N, Kumar U, Samant SS. Antioxidant properties, phenolics and flavonoids content of some economically important plants from North-west Indian himalaya. Nat Prod Res. 2022;36:1565\u20139. https:\/\/doi.org\/10.1080\/14786419.2021.1881959.","journal-title":"Nat Prod Res"},{"key":"4918_CR76","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.3390\/nu16091396","volume":"16","author":"NM Trang","year":"2024","unstructured":"Trang NM, Vinh LB, Phong NV, Yang SY. Traditional uses, phytochemistry, and Pharmacological activities of Vernonia cinerea (L.) less. Updated Rev Nutrients. 2024;16:1396. https:\/\/doi.org\/10.3390\/nu16091396.","journal-title":"Updated Rev Nutrients"},{"key":"4918_CR77","doi-asserted-by":"publisher","first-page":"219","DOI":"10.26656\/fr.2017.8(2).227","volume":"8","author":"A Izyani","year":"2024","unstructured":"Izyani A, Abdul majid F, Nurazwa S, Ismail H. Bioprospecting of Vernonia cinerea for nutraceutical and homemade first aid remedies: a review update. Food Res. 2024;8:219\u201332. https:\/\/doi.org\/10.26656\/fr.2017.8(2).227.","journal-title":"Food Res"},{"key":"4918_CR78","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.fitote.2013.12.013","volume":"93","author":"UJ Youn","year":"2014","unstructured":"Youn UJ, Miklossy G, Chai X, Wongwiwatthananukit S, Toyama O, Songsak T, et al. Bioactive sesquiterpene lactones and other compounds isolated from Vernonia cinerea. Fitoterapia. 2014;93:194\u2013200. https:\/\/doi.org\/10.1016\/j.fitote.2013.12.013.","journal-title":"Fitoterapia"},{"key":"4918_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4038\/cjms.v42i1.4882","volume":"42","author":"MI Thabrew","year":"1999","unstructured":"Thabrew MI, Jayatilaka KAPW. A comparative study of the beneficial effects of Osbeckia Octandra and Osbeckia aspera in liver dysfunction in rats. Cey J Med Sci. 1999;42:1. https:\/\/doi.org\/10.4038\/cjms.v42i1.4882.","journal-title":"Cey J Med Sci"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-04918-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-04918-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T12:41:48Z","timestamp":1748004108000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-04918-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4918"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-04918-7","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"1 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Committee for Ethical Clearance on Animal Research of Faculty of Veterinary Medicine and Animal Science, University of Peradeniya. (protocol code: 20400, date of approval: 10.12.2020, Id: VERC-20-08)","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consented for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}